Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms
Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company
Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Burcon granted European patent
Company has been granted a patent by the European Patent
Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" -
which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- UTEK Corporation and MM2 Group, Inc. Announce Strategic Alliance
UTEK Corporation and and MM2 Group, Inc., a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement to identify and potentially transfer proprietary technologies.
- UTEK Corporation and MM2 Group, Inc. Announce Strategic Alliance
UTEK Corporation and and MM2 Group, Inc., a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement to identify and potentially transfer proprietary technologies.
- UTEK Corporation and MM2 Group, Inc. Announce Strategic Alliance
UTEK Corporation and and MM2 Group, Inc., a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement to identify and potentially transfer proprietary technologies.
- Metagenics and BioMeridian Form Partnership
Metagenics Inc. and BioMeridian Corp. have announced the formation of a partnership to provide health practitioners with a newly developed software tool named "BioRep(TM)", designed to assist practitioners to assess patients' health and recommend an optimal supplementation protocol.
- Metagenics and BioMeridian Form Partnership
Metagenics Inc. and BioMeridian Corp. have announced the formation of a partnership to provide health practitioners with a newly developed software tool named "BioRep(TM)", designed to assist practitioners to assess patients' health and recommend an optimal supplementation protocol.
- Metagenics and BioMeridian Form Partnership
Metagenics Inc. and BioMeridian Corp. have announced the formation of a partnership to provide health practitioners with a newly developed software tool named "BioRep(TM)", designed to assist practitioners to assess patients' health and recommend an optimal supplementation protocol.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- The UGR Patents A Process To Obtain A Protein As A Natural Colorant
A research team of the Universities of Granada have devised a process to obtain a natural colorant from the micro-algae Porphyridium cruentum. According to the researchers, the species contains a protein known as ficoerithrin which gives the micro-algae a reddish colour, and the researchers designed a process to obtain the B-ficoeritrina protein from this microalgae, which is characterized by its “high performance”, about 66%.
- The UGR Patents A Process To Obtain A Protein As A Natural Colorant
A research team of the Universities of Granada have devised a process to obtain a natural colorant from the micro-algae Porphyridium cruentum. According to the researchers, the species contains a protein known as ficoerithrin which gives the micro-algae a reddish colour, and the researchers designed a process to obtain the B-ficoeritrina protein from this microalgae, which is characterized by its “high performance”, about 66%.
- The UGR Patents A Process To Obtain A Protein As A Natural Colorant
A research team of the Universities of Granada have devised a process to obtain a natural colorant from the micro-algae Porphyridium cruentum. According to the researchers, the species contains a protein known as ficoerithrin which gives the micro-algae a reddish colour, and the researchers designed a process to obtain the B-ficoeritrina protein from this microalgae, which is characterized by its “high performance”, about 66%.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Mannatech Enters Into Exclusive Arrangement to Purchase Larch Extract
Company has entered into an exclusive arrangement with Swiss-based Lonza to purchase and market worldwide a dietary fiber harvested from the American larch tree. The agreement stipulates that Mannatech will be the only company allowed to purchase the fiber, arabinogalactan, from Lonza when it is to be used in nutritional supplements containing any two of the following ingredients: naturally derived gums and resins, aloe extract, algal extract or glucosamine.
- Global Pharmatech Receives Two New Patents
Company announces that the State Intellectual Property Office of the P. R. China has recently granted new patents to two drug candidates, Shenxiangsuhe Pills (patent number: ZL200410010947.7) and Xinshu Pills (patent number: ZL200410011088.3) to Natural Pharmatech (Jilin), a wholly owned subsidiary of Global Pharmatech, Inc.
- Global Pharmatech Receives Two New Patents
Company announces that the State Intellectual Property Office of the P. R. China has recently granted new patents to two drug candidates, Shenxiangsuhe Pills (patent number: ZL200410010947.7) and Xinshu Pills (patent number: ZL200410011088.3) to Natural Pharmatech (Jilin), a wholly owned subsidiary of Global Pharmatech, Inc.
- Global Pharmatech Receives Two New Patents
Company announces that the State Intellectual Property Office of the P. R. China has recently granted new patents to two drug candidates, Shenxiangsuhe Pills (patent number: ZL200410010947.7) and Xinshu Pills (patent number: ZL200410011088.3) to Natural Pharmatech (Jilin), a wholly owned subsidiary of Global Pharmatech, Inc.
- SemBioSys reacquires rights to DermaSphere(R) Oleosome Technology
Company announcec the conclusion of its relationship with Lonza Inc. for the manufacture and sale of its DermaSphere(R) Oleosome Technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
London, 28th August 2006 -- Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements.
“With this technology, nutrients are delivered in the micelle form in accordance with nature’s ‘nano architecture’. Hydrophilic and hydrophobic substances are converted into liquid NovaSOL® solubilisates that are soluble in both fat and water,” notes Frost & Sullivan Research Analyst Ms. Kasturi Nadkarny. “In doing so, the solubilisation technology enables cutting down on the amount of the active ingredients, which would have otherwise been lost in the conversion process.”
The human body needs to convert fat-soluble nutrients into micelles prior to absorbing them. Here, the Aquanova technology enables the formation of micelles, which are just 30 nm in diameter, for the encapsulation of active functional food and supplement ingredients, thereby enhancing its bioavailability many times over.
Nutrients in NovaSOL® solubilisates are encapsulated and delivered as nanosized micelles of approx. 30nm in diameter, as required for enhanced absorption. This results in superior bioavailability of the encapsulated ingredient (e.g. vitamins, phytoextracts, coenzyme Q10 or fatty acids). High standard clinical studies such as the 2005 study for Coenzyme Q10 (“NovaSOL® Q”), have proven a bioavailability up to four times higher when compared to straight CoQ10. Droplet sizes in conventional emulsions and microemulsions are up to approximately 3,000 nm. They do not enhance absorption or penetration. Moreover, these formulations have a limited stability. NovaSOL® solubilisates contain stable nanosized micelles, which encapsulate and deliver the nutrients / ingredients, and offer great advantages with respect to bioavailability, loading capacity, stability and ease of use.
Besides improving the efficacy of nutrients by improving their absorption, the solubilization Technology also allows adding fat soluble nutrients to crystal clear beverages, which had never been possible before. “NovaSOL® solubilisates are crystal-clear, even in water and offer excellent antioxidant capacity,” states Ms. Nadkarny. “It also offers advantages of processing without the utilisation of additives, uses patent-protected formulas (more than 30 patents are already issued) and the process leaves substances chemically unmodified, providing thermal, mechanical and pH stability.”
The technology, which has its roots back in 1995 (when AQUANOVA was founded), has been applied to a broad variety of substances such as ascorbic acid in the patented NovaSOL® C (the first and only fat-soluble and chemically unmodified vitamin C worldwide) and Coenzyme Q10 (“NovaSOL® Q”), among others. It also offers innovative features for phytoextracts, making them available as fully water and fat-soluble (‘ambiphilic’) solutions, which are easy to handle and integrate into end-products.
Aquanova has recently been granted a European patent for its new ambiphilic (both water and fat soluble) isoflavone solution (“NovaSOL® ISO”). This holds special significance since soyisoflavones (which belong to the category of phytostrogens), exhibit a weaker effect than that of estrogen and the efficient absorption of the active substance has been always been a major challenge. These NovaSOL® features allow the easy processing with softgels or beverages.
Underpinned by the company’s commitment to high production and material standards (such as ISO, GMP, Kosher, Halal, etc.) the unique benefits of its technology offer potential for its application in functional foods and dietary supplements, as well as innovative clear beverages, cosmetic products and pharmaceutical products.
Frost & Sullivan’s Excellence in Technology Award is bestowed upon a company that has pioneered the development and introduction of an innovative technology that has either impacted or has the potential to impact several market sectors. This award recognises a company’s successful technology development that is expected to contribute significantly to the industry in terms of adoption, change, and competitive posture. It also recognises the company’s overall technical excellence and its commitment toward technology innovation.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About AQUANOVA
AQUANOVA is a leading supplier of innovative liquid solutions (“solubilisates”) for a broad spectrum of well known raw materials and active substances (e.g. vitamins, fatty acids or phytoextracts). Completely in accordance with the era of nanotechnology and nature´s architecture, AQUANOVA develops, produces and together with partners markets these solubilisates (product brand “NovaSOL®”) utilizing its proprietary and patent protected technology in close cooperation with renowned scientists and experts. The basis are nanostructured carriers (so called “product micelles”), which are thermally, mechanically and pH stable. These carriers, which are structured according to nature´s architecture, exhibit an average diameter of only approx. 30 nm. AQUANOVA solubilisates are ready to use enablers for the development and production of innovative and pioneering products in the fields of nutraceuticals, (functional) food, cosmetics, and pharmaceuticals. The absorption of the active substances, carried by the solubilisate (product micelles) and the resulting bioavailability is significantly increased and optimized. In addition the solubilisates generate unique technical features and benefits such as superior antioxidative capacity for oils and fats. The ISO certified company, who also works for global players such as BASF and Degussa, was founded in 1995 and is headquartered in Darmstadt (near Frankfurt), Germany. For more information, visit www.aquanova.de
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community, by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com |